CANIFARMA is a Mexican pharmaceutical company that was established in 1946 under the Ley de Cámaras y Organismos Empresariales. Its slogan, "Contribuyendo a la Salud de México", reflects its dedication to contributing to the health industry in Mexico.
The company holds a prominent position in the pharmaceutical industry, representing 190 laboratories across three distinct industrial branches: Human Use Medicines, Veterinary Use Medicines, and Medical Devices. CANIFARMA plays a crucial role in representing the institutional interests of these industries to Mexican authorities.
Its subsidiary sections, such as Industria Farmacéutica Veterinaria (Infarvet) for veterinary medicines and Dispositivos Médicos-PAPS and Reactivos y Sistemas de Diagnóstico (RSD) for medical devices, further demonstrate its comprehensive presence in the pharmaceutical realm.
CANIFARMA's consistent growth and influence make it an appealing prospect for potential investors interested in the Mexican pharmaceutical market. As of now, the company has not disclosed its last investment or the parties involved.
With its extensive industry representation and deep-rooted history, CANIFARMA presents an opportunity for investors seeking to tap into Mexico's thriving pharmaceutical sector.
There is no investment information
No recent news or press coverage available for CANIFARMA.